To determine whether ZAK silencing inhibits in vivo metastatic ability of MDA-MB-231 cells, bioluminescence imaging (BLI) was used to monitor and compare metastatic tumor growth caused by MDA-MB-231-shCtrl cells and MDA-MB-231-shZAK cells. Here, MAP3K20 is linked to neoplasm.